½ÃÀ庸°í¼­
»óǰÄÚµå
1391913

¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå : À¯Çüº°, ±â¼úº°, ¼­ºñ½º Á¦°øÀÚº°, Áö¿ªº°

Esoteric Testing Market, By Type, By Technology, By Service Provider, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 259¾ï ´Þ·¯¿¡¼­ 2030³â 549¾ï ´Þ·¯¿¡ ´ÞÇϰí, ¿¹Ãø ±â°£ µ¿¾È 11.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2022³â 2023³â ½ÃÀå ±Ô¸ð 259¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ÀÇ CAGR 11.30% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 549¾ï ´Þ·¯
±×¸² 1. ¿¡¼ÒÅ׸¯ °Ë»ç ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Esoteric Testing Market- IMG1

±â¼ú°ú ÀÇÇÐ ¿¬±¸ÀÇ ¹ßÀüÀ¸·Î °íµµ·Î Àü¹®È­µÈ Áø´Ü °Ë»ç°¡ °³¹ßµÊ¿¡ µû¶ó ÃÖ±Ù ¿¡¼ÒÅ׸¯ °Ë»ç ºÐ¾ß°¡ Å« ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¿¡¼ÒÅ׸¯ °Ë»ç¶õ ÀϹÝÀûÀ¸·Î ½ÃÇàµÇÁö ¾Ê°í Àü¹® Àåºñ, Àü¹® Áö½Ä ¹× ÇØ¼®ÀÌ ÇÊ¿äÇÑ ÀÓ»ó °Ë»ç¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â Èñ±Í ÁúȯÀÇ Áø´Ü, Ä¡·á È¿°ú ¸ð´ÏÅ͸µ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç Á¦°ø¿¡ Ȱ¿ëµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

¼¼°è ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, À¯ÀüÀÚ °Ë»çÀÇ ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¿¡¼ÒÅ׸¯ °Ë»ç´Â À¯ÀüÀÚ µ¹¿¬º¯ÀÌ, ¹ÙÀÌ¿À¸¶Ä¿ ¹× ±âŸ ºÐÀÚ ÀÌ»óÀ» ½Äº°ÇÏ¿© Áúº´À» Á¶±â¿¡ ¹ß°ßÇϰí Ä¡·áÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀåÀº ÁÖ·Î ¾Ï, ½ÉÇ÷°ü Áúȯ, ÀÚ°¡¸é¿ª Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¡¼ÒÅ׸¯ Å×½ºÆ®´Â ÀÇ·á Àü¹®°¡°¡ ÀÌ·¯ÇÑ Áúº´°ú °ü·ÃµÈ ƯÁ¤ À¯ÀüÀÚ º¯ÀÌ ¹× ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°ÇÏ¿© Á¶±â Áø´Ü ¹× °³º°È­µÈ Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, Á¤¹ÐÀÇ·á¿Í Ç¥ÀûÄ¡·áÀÇ µµÀÔÀÌ È®´ëµÇ¸é¼­ ¿¡¼ÒÅ׸¯ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ¿¡¼ÒÅ׸¯ °Ë»ç´Â °í°¡ÀÇ ºñ¿ë, ºÒÃæºÐÇÑ º¸»ó Á¤Ã¥ µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¿¡¼ÒÅ׸¯ °Ë»ç´Â Ư¼ö Àåºñ¿Í Àü¹® Áö½ÄÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ºñ¿ëÀÌ ¸¹ÀÌ µå´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, º¸Çè»çÀÇ º¸Çè Àû¿ëÀÌ Á¦ÇÑÀûÀ̶ó´Â Á¡µµ ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ÀÌ·¯ÇÑ °Ë»çÀÇ º¸±ÞÀ» °¡·Î¸·°í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ½ÃÀå¿¡´Â ¸î °¡Áö ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ¿¹¹æÀÇÇп¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Áúº´ Á¶±â ¹ß°ßÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼¼Æ÷°Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Â÷¼¼´ë ½ÃÄö½Ì ¹× ºÐÀÚ Áø´Ü°ú °°Àº ±â¼úÀÇ ¹ßÀüÀº ¿¡¼ÒÅ׸¯ °Ë»çÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» ¿­¾îÁÙ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­´Â 2022³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR %)À» Æ÷ÇÔÇÑ ¼¼°è ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®Çß½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×µµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷ÀÇ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
  • ¸¸¼ºÁúȯÀ̳ª °¨¿°Áõ ÀÌȯÀ² »ó½Â
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °í¾×ÀÇ ºñ¿ë°ú ºÒÃæºÐÇÑ »óȯ
    • ±âȸ
  • POC(Point of Care) ¿¡¼ÒÅ׸¯ °Ë»ç
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porters ºÐ¼®
  • ÀμöÇÕº´ ½Ã³ª¸®¿À

Á¦4Àå ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå, À¯Çüº°, 2018-2030³â

  • ¼­·Ð
  • ³»ºÐºñÇÐ
  • Á¾¾çÇÐ
  • ºÐÀÚÁø´ÜÇÐ
  • ½Å°æ³»°ú
  • ¸é¿ªÇÐ
  • À¯ÀüÀÚ °Ë»ç
  • ±âŸ

Á¦6Àå ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå, ±â¼úº°, 2018-2030³â

  • ¼­·Ð
  • Áú·®ºÐ¼®¹ý
  • ½Ç½Ã°£ PCR
  • À¯¼¼Æ÷ ºÐ¼®
  • È­Çй߱¤
  • ELISA
  • ¹æ»ç¸é¿ªÃøÁ¤¹ý
  • ±âŸ

Á¦7Àå ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå, ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õº°, 2018-2030³â

  • ¼­·Ð
  • µ¶¸³Çü ¿¬±¸¼Ò¿Í Ç¥ÁØ ½ÇÇè½Ç
  • º´¿ø ±â¹Ý °Ë»ç±â°ü
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦8Àå ¿¡¼ÒÅ׸¯ °Ë»ç ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ¼­·Ð
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN ±¹°¡
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦9Àå °æÀï »óȲ

  • LabCorp
  • Quest Diagnostics
  • OPKO Health
  • Miraca Holdings
  • Myriad Genetics
  • Sonic Healthcare
  • Cardio Diagnostics Holdings, Inc
  • Veravas
  • BPGbio, Inc.
  • Fulgent Genetics
  • Alveo Technologies, Inc.
  • R.L. Diagnostics

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 23.12.15

The esoteric testing market size is expected to reach US$ 54.9 billion by 2030, from US$ 25.9 million in 2023, at a CAGR of 11.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 25.9 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 11.30% 2030 Value Projection: US$ 54.9 Bn
Figure 1. Global Esoteric Testing Market Share (%), by Region, 2023
Esoteric Testing Market - IMG1

The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.

The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.

Market Dynamics:

The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.

However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.

Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global esoteric testing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market

Esoteric Testing Market Segmentation

  • By Type
    • Endocrinology
    • Oncology
    • Molecular Diagnostics
    • Neurology
    • Immunology
    • Genetic Testing
    • Others
  • By Technology
    • Mass Spectrometry
    • Real Time PCR
    • Flow Cytometry
    • Chemiluminescence
    • ELISA
    • Radioimmunoassay
    • Others
  • By Service Provider
    • Independent & Reference Labs
    • Hospital-based Labs
    • Specialty Clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Esoteric Testing Market
    • LabCorp
    • Quest Diagnostics
    • OPKO Health
    • Miraca Holdings
    • Myriad Genetics
    • Sonic Healthcare
    • Cardio Diagnostics Holdings, Inc
    • Veravas
    • BPGbio, Inc.
    • Fulgent Genetics
    • Alveo Technologies, Inc.
    • S.R.L. Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Esoteric Testing, By Type
    • Market Esoteric Testing, By Technology
    • Market Esoteric Testing, By Service Provider
    • Market Esoteric Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of chronic and infectious diseases
    • Restraints
  • High costs and inadequate reimbursements
    • Opportunities
  • Point-of-care esoteric testing
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Esoteric Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Esoteric Testing Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Genetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Esoteric Testing Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Real Time PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Chemiluminescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Radioimmunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Esoteric Testing Market, By Service Provider, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Independent & Reference Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Hospital-based Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Esoteric Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • LabCorp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • OPKO Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miraca Holdings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Myriad Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sonic Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cardio Diagnostics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Veravas
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BPGbio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fulgent Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alveo Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R.L. Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦